An inoganic sodium salt with formula with formula NaAsO2.
Chemical ID:
MESH:C017947
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
CDKN1B protein affects the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein]; Curcumin inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein]; Drugs, Chinese Herbal inhibits the reaction [sodium arsenite results in increased expression of MAPK9 protein modified form]; MAPK9 protein affects the reaction [sodium arsenite results in increased expression of HSPA1A protein]; MAPK9 protein affects the reaction [sodium arsenite results in increased expression of HSPB1 protein]; MAPK9 protein affects the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of HSF1 protein]; MAPK9 protein promotes the reaction [sodium arsenite results in increased activity of CASP3 protein]; MAPK9 protein promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein]; MAPK9 protein promotes the reaction [sodium arsenite results in increased expression of GADD45A mRNA]; MAPK9 protein promotes the reaction [sodium arsenite results in increased expression of GADD45A protein]; MAPK9 protein promotes the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of JUN protein]; sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK9 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein]; [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein; Curcumin inhibits the reaction [sodium arsenite results in increased expression of MAPK9 protein]; Curcumin inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein]; O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [sodium arsenite results in increased activity of MAPK9 protein]; Vinyl Compounds analog inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein]
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA; sodium arsenite promotes the reaction [MAPK8 protein binds to MAPK9 protein binds to TP53 protein modified form]; tetramethylpyrazine inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein]
